🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 9 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/04/1997 | 38,37 | 38,37 | 36,96 | 38,37 | +1,23% | 3,66% | 94.123 |
| 09/04/1997 | 38,60 | 39,30 | 37,43 | 37,90 | -2,41% | 4,85% | 66.685 |
| 08/04/1997 | 38,37 | 38,83 | 36,49 | 38,83 | +2,47% | 6,10% | 85.707 |
| 07/04/1997 | 38,37 | 39,30 | 37,43 | 37,90 | -1,22% | 4,88% | 98.531 |
| 04/04/1997 | 39,30 | 39,77 | 37,90 | 38,37 | -2,38% | 4,76% | 45.124 |
| 03/04/1997 | 39,77 | 40,24 | 38,83 | 39,30 | +0,00% | 3,53% | 51.617 |
| 02/04/1997 | 40,70 | 41,17 | 38,37 | 39,30 | -1,18% | 6,90% | 53.701 |
| 01/04/1997 | 41,64 | 42,11 | 39,30 | 39,77 | -4,49% | 6,74% | 54.395 |
| 31/03/1997 | 44,45 | 44,45 | 39,77 | 41,64 | -5,32% | 10,53% | 44.804 |
| 27/03/1997 | 47,26 | 47,26 | 43,98 | 43,98 | +1,08% | 6,93% | 53.273 |
| 26/03/1997 | 39,30 | 44,45 | 39,30 | 43,51 | +10,71% | 13,10% | 63.131 |
| 25/03/1997 | 39,77 | 39,77 | 38,83 | 39,30 | +0,00% | 2,35% | 79.776 |
| 24/03/1997 | 40,24 | 40,24 | 38,83 | 39,30 | +0,00% | 3,49% | 54.609 |
| 21/03/1997 | 42,58 | 42,58 | 38,37 | 39,30 | -4,55% | 9,89% | 100.775 |
| 20/03/1997 | 42,58 | 43,04 | 40,70 | 41,17 | -0,56% | 5,49% | 67.887 |
| 19/03/1997 | 44,45 | 44,45 | 40,24 | 41,41 | -6,84% | 9,47% | 86.001 |
| 18/03/1997 | 44,92 | 44,92 | 43,98 | 44,45 | -2,06% | 2,08% | 29.255 |
| 17/03/1997 | 46,79 | 47,26 | 45,38 | 45,38 | -3,96% | 4,00% | 49.426 |
| 14/03/1997 | 46,79 | 47,26 | 45,85 | 47,26 | +1,00% | 3,00% | 32.300 |
| 13/03/1997 | 46,79 | 47,26 | 45,38 | 46,79 | +1,01% | 4,00% | 33.930 |
| 12/03/1997 | 47,72 | 47,72 | 44,45 | 46,32 | -2,46% | 6,86% | 62.009 |
| 11/03/1997 | 48,19 | 48,19 | 46,79 | 47,49 | +0,50% | 2,91% | 34.892 |
| 10/03/1997 | 46,79 | 48,19 | 46,79 | 47,26 | +0,00% | 3,00% | 16.083 |
| 07/03/1997 | 47,26 | 48,19 | 46,79 | 47,26 | -0,98% | 2,97% | 17.580 |
| 06/03/1997 | 47,72 | 48,19 | 46,79 | 47,72 | +0,00% | 2,94% | 35.186 |
| 05/03/1997 | 48,66 | 49,13 | 47,26 | 47,72 | -1,92% | 3,85% | 34.277 |
| 04/03/1997 | 47,26 | 49,13 | 46,79 | 48,66 | +6,12% | 4,95% | 100.455 |
| 03/03/1997 | 45,38 | 46,32 | 45,38 | 45,85 | +1,03% | 2,06% | 42.480 |
| 28/02/1997 | 45,38 | 46,32 | 44,45 | 45,38 | +0,00% | 4,12% | 33.663 |
| 27/02/1997 | 48,66 | 48,66 | 43,51 | 45,38 | -4,90% | 10,58% | 147.342 |